To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MED13LTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
431 supporting clones for gene MED13L back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AY338463   .a 1 to 9528 1 to 9529 exact tiling clone, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 9529/9529
(100 %)
2 diff
(100.0 %id)
TI_1607544895   .a 149 to 604 611 to 156       456/681
(66 %)
3 diff
(99.6 %id)
AF515599   .a 153 to 9528 1 to 9377       9377/9377
(100 %)
4 diff
(100.0 %id)
NM_015335.4   .a 153 to 9528 1 to 9376   RefSeq, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 9376/9376
(100 %)
0 diff
(100 %id)
BC130422 Cerebellum, Lung, PCR rescued clones .a 157 to 8179 1 to 8023       8023/8023
(100 %)
0 diff
(100 %id)
BQ359011 head_neck .a 245 to 523 7 to 287       281/290
(96 %)
15 diff
(94.9 %id)
TI_1607547945   .a 512 to 1379 1 to 864       863/962
(89 %)
21 diff
(97.9 %id)
BQ310414 breast .a 515 to 1114 596 to 1       596/602
(99 %)
14 diff
(97.7 %id)
BQ310416 breast .a 531 to 1122 622 to 30       593/622
(95 %)
6 diff
(99.1 %id)
BX281395 placenta .a 540 to 1009 470 to 1     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
AW290971   .a 569 to 963 396 to 3   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 394/396
(99 %)
0 diff
(100 %id)
R77571 placenta .a 594 to 874 283 to 1     Submitted on the opposite strand 283/328
(86 %)
6 diff
(98.2 %id)
AK127706   .a 619 to 4609 1 to 3991   available from FLJ,   3991/3991
(100 %)
3 diff
(100.0 %id)
DA726263   .a 620 to 1197 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
CR749332 fetal kidney .a 629 to 9527 1 to 8897   available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 8897/8897
(100 %)
11 diff
(99.9 %id)
BF895666 marrow .a 685 to 1125 40 to 478       440/478
(92 %)
7 diff
(98.6 %id)
H03556 placenta .a 685 to 1010 326 to 1     Submitted on the opposite strand 326/412
(79 %)
0 diff
(100 %id)
AW612176 carcinoid, lung .a 685 to 947 264 to 1       264/294
(89 %)
1 diff
(99.7 %id)
BQ310570 breast .a 700 to 1122 448 to 19       430/449
(95 %)
20 diff
(95.6 %id)
CF995709 mixed .a 756 to 1571 1 to 812       812/814
(99 %)
18 diff
(97.8 %id)
TI_1607547773   .a 761 to 1515 13 to 770       758/771
(98 %)
12 diff
(98.5 %id)
DR001150 fetal brain .a 789 to 1484 1 to 696       696/696
(100 %)
5 diff
(99.3 %id)
T07653   .a 913 to 1213 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
AA283113 germinal center B cell .a 1080 to 1529 451 to 1     Submitted on the opposite strand 451/451
(100 %)
22 diff
(95.2 %id)
AB028948 brain .a 1096 to 9528 11 to 8444   available from KIAA,   8434/8444
(99 %)
9 diff
(99.9 %id)
AL133033 uterus .a 1113 to 9528 1 to 8417   available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 8417/8417
(100 %)
2 diff
(100.0 %id)
BF753143 breast_normal .a 1174 to 1345 170 to 1     Submitted on the opposite strand 170/177
(96 %)
13 diff
(92.7 %id)
BU169889 embryonal carcinoma, cell line, testis .a 1188 to 2031 1 to 858       858/860
(99 %)
24 diff
(97.3 %id)
AI095686 uterus .a 1194 to 1617 425 to 2       424/425
(99 %)
0 diff
(100 %id)
BG001130 placenta_normal .a 1370 to 1723 367 to 14       354/367
(96 %)
0 diff
(100 %id)
BF801403 colon_ins .a 1762 to 2180 8 to 426       419/426
(98 %)
6 diff
(98.6 %id)
DA334940 hippocampus .a 1784 to 2353 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CN358454 embryonic stem cells, cell lines H1, H7, andH9 .a 1822 to 2361 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
DN920399   .a 2333 to 2677 380 to 36       345/380
(90 %)
1 diff
(99.8 %id)
DA337276 hippocampus .a 2400 to 2979 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BU186877 embryonal carcinoma, cell line, testis .a 2400 to 3206 1 to 809       809/903
(89 %)
4 diff
(99.6 %id)
AW994533 breast_normal .a 2487 to 2733 5 to 250       246/250
(98 %)
6 diff
(97.6 %id)
BE694084 breast .a 2487 to 2733 5 to 250       246/250
(98 %)
6 diff
(97.6 %id)
TI_1607544877   .a 2584 to 3264 10 to 692       683/965
(70 %)
25 diff
(97.5 %id)
TI_1607547969   .a 2627 to 3465 8 to 847       840/849
(98 %)
16 diff
(98.2 %id)
BM723618 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2965 to 3388 1 to 424   fully sequenced,   424/424
(100 %)
5 diff
(98.9 %id)
BM559194 eye, retinoblastoma .a 3011 to 3972 1 to 976       976/991
(98 %)
35 diff
(96.5 %id)
BU741032 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3086 to 3388 340 to 38   fully sequenced, AAA   303/315
(96 %)
0 diff
(100 %id)
DN912724   .a 3148 to 3337 190 to 1       190/190
(100 %)
0 diff
(100 %id)
DB085417 testis .a 3154 to 3705 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
EH315690   .a 3165 to 3225 1 to 60       60/60
(100 %)
1 diff
(98.4 %id)
BF928824 nervous_tumor .a 3189 to 3470 282 to 1     Submitted on the opposite strand 282/282
(100 %)
1 diff
(99.7 %id)
BF951108 nervous_normal .a 3209 to 3456 279 to 34       246/292
(84 %)
0 diff
(100 %id)
DB070665 testis .a 3303 to 3846 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB218327 trachea .a 3303 to 3783 2 to 483   capped   482/482
(100 %)
1 diff
(99.8 %id)
DB071150 testis .a 3346 to 3870 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
AW501074 lymph .a 3354 to 3817 1 to 464       464/464
(100 %)
4 diff
(99.2 %id)
TI_154155618   .a 3361 to 3836 83 to 558       476/477
(99 %)
1 diff
(99.8 %id)
BI014210 lung_tumor .a 3374 to 3889 9 to 521       513/521
(98 %)
6 diff
(98.9 %id)
DB282530 uterus .a 3384 to 3935 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA814489   .a 3387 to 3893 2 to 508   capped   507/507
(100 %)
1 diff
(99.9 %id)
AK023837 placenta .a 3436 to 8264 1 to 4829   available from FLJ,   4829/4829
(100 %)
9 diff
(99.9 %id)
AU140855 placenta .a 3437 to 4141 2 to 707   capped   706/754
(93 %)
3 diff
(99.7 %id)
TI_1607547951   .a 3458 to 4258 1 to 806       806/806
(100 %)
15 diff
(98.2 %id)
BI027447 marrow .a 3459 to 3874 10 to 422       413/422
(97 %)
6 diff
(98.6 %id)
BQ308350 breast .a 3472 to 3958 1 to 490       490/490
(100 %)
27 diff
(94.5 %id)
BF742847 breast .a 3496 to 3904 1 to 410       410/410
(100 %)
4 diff
(99.1 %id)
BQ304184 breast .a 3496 to 3841 1 to 346       346/346
(100 %)
2 diff
(99.5 %id)
BF855858 prostate_normal .a 3526 to 3800 278 to 5     Submitted on the opposite strand 274/278
(98 %)
0 diff
(100 %id)
DB161270 thymus .a 3586 to 4185 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
BE711031 head_neck .a 3666 to 3993 8 to 335       328/335
(97 %)
6 diff
(98.3 %id)
BE827064 lung_tumor .a 3668 to 4039 7 to 378       372/378
(98 %)
6 diff
(98.5 %id)
BE710989 head_neck .a 3670 to 4061 391 to 1       391/391
(100 %)
3 diff
(99.3 %id)
BU509038 leiomyosarcoma, uterus .a 3703 to 4517 1 to 822       822/914
(89 %)
12 diff
(98.7 %id)
BE710999 head_neck .a 3708 to 4068 360 to 1       360/360
(100 %)
6 diff
(98.4 %id)
BX474013   .a 3725 to 4166 1 to 442       442/442
(100 %)
1 diff
(99.8 %id)
BE827072 lung_tumor .a 3735 to 3992 19 to 276       258/276
(93 %)
6 diff
(97.9 %id)
AL707987 human skeletal muscle .a 3755 to 4331 1 to 577       577/577
(100 %)
6 diff
(99.0 %id)
CN358456 embryonic stem cells, cell lines H1, H7, andH9 .a 3770 to 4481 1 to 712       712/712
(100 %)
3 diff
(99.6 %id)
AL712641 human skeletal muscle .a 3805 to 4320 1 to 517       517/517
(100 %)
1 diff
(99.9 %id)
AU140574 placenta .a 3933 to 4677 2 to 745   capped   744/746
(99 %)
7 diff
(99.1 %id)
DB324382   .a 4034 to 4609 577 to 1       577/577
(100 %)
7 diff
(98.8 %id)
DB280862 uterus .a 4036 to 4518 59 to 541   capped   483/540
(89 %)
6 diff
(98.9 %id)
BU428732 lymph .a 4066 to 4553 1 to 488       488/488
(100 %)
5 diff
(99.0 %id)
BU430538 lymph .a 4066 to 4480 1 to 416       416/416
(100 %)
13 diff
(96.9 %id)
TI_154149572   .a 4073 to 4572 80 to 579       500/501
(99 %)
1 diff
(99.9 %id)
TI_154151951   .a 4073 to 4542 78 to 548       471/476
(98 %)
15 diff
(96.9 %id)
BG008403 placenta_normal .a 4097 to 4552 6 to 460       455/460
(98 %)
6 diff
(98.7 %id)
AW361914 colon .a 4115 to 4405 1 to 290       290/290
(100 %)
4 diff
(98.7 %id)
TI_1607547947   .a 4116 to 4947 17 to 846       830/846
(98 %)
23 diff
(97.3 %id)
BI049699 placenta_normal .a 4209 to 4545 1 to 338       338/338
(100 %)
6 diff
(98.3 %id)
DB122362 thymus .a 4222 to 4800 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
BQ307633 breast .a 4230 to 4807 587 to 7       581/587
(98 %)
3 diff
(99.5 %id)
CN358455 embryonic stem cells, DMSO-treated H9 cellline .a 4250 to 4795 1 to 546       546/546
(100 %)
0 diff
(100 %id)
DB285811 uterus .a 4296 to 4847 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BQ580385   .a 4370 to 4800 431 to 1       431/431
(100 %)
0 diff
(100 %id)
BE836335 prostate_normal .a 4422 to 4733 1 to 311       311/320
(97 %)
7 diff
(97.9 %id)
BE715784 head_neck .a 4423 to 4811 393 to 5       389/395
(98 %)
1 diff
(99.8 %id)
BE715788 head_neck .a 4423 to 4811 392 to 5       388/394
(98 %)
2 diff
(99.5 %id)
BE836192 prostate_normal .a 4423 to 4733 16 to 323       308/332
(92 %)
10 diff
(97.0 %id)
BF372559 prostate_tumor .a 4423 to 4612 11 to 194       184/194
(94 %)
8 diff
(95.9 %id)
DA331697 hippocampus .a 4484 to 5081 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA557732   .a 4516 to 4978 2 to 469   capped   468/468
(100 %)
6 diff
(98.8 %id)
DA093913 cerebellum .a 4517 to 5071 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
TI_1607547941   .a 4543 to 5381 7 to 847       843/847
(99 %)
8 diff
(99.1 %id)
BG106113 lymph, lymphoma, cell line .a 4578 to 5247 1 to 662       662/663
(99 %)
13 diff
(98.1 %id)
H85495 melanocyte .a 4650 to 4981 1 to 334       334/373
(89 %)
2 diff
(99.5 %id)
DA859297 placenta .a 4660 to 5194 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DA809088 brain .a 4712 to 5244 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BQ304116 breast .a 4731 to 4964 5 to 238       234/238
(98 %)
6 diff
(97.5 %id)
DA197446 brain .a 4736 to 5301 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DB064658 testis .a 4744 to 5281 2 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
AI909786 breast .a 4814 to 5308 1 to 488       488/494
(98 %)
36 diff
(92.8 %id)
BF154567 breast_normal .a 4826 to 5160 346 to 8       339/359
(94 %)
0 diff
(100 %id)
AW365107 denis_drash .a 4860 to 5319 1 to 461       461/461
(100 %)
9 diff
(98.1 %id)
BX642991   .a 4861 to 5376 1 to 519       519/519
(100 %)
5 diff
(99.1 %id)
AA226992 brain, neuroepithelial cells .a 4869 to 5185 1 to 318       318/318
(100 %)
2 diff
(99.4 %id)
AW938788 denis_drash .a 4882 to 5317 1 to 436       436/438
(99 %)
5 diff
(98.9 %id)
AW365084 denis_drash .a 4888 to 5317 1 to 431       431/433
(99 %)
13 diff
(97.0 %id)
BE300613 carcinoma cell line, cervix .a 4910 to 5534 1 to 626     Submitted on the opposite strand 626/626
(100 %)
3 diff
(99.6 %id)
CN358453 embryonic stem cells, cell lines H1, H7, andH9 .a 4914 to 5351 1 to 438       438/438
(100 %)
0 diff
(100 %id)
DA647662   .a 4914 to 5452 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CN358451 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4916 to 5351 1 to 436       436/436
(100 %)
0 diff
(100 %id)
BX498028 Liver .a 5025 to 5264 1 to 240       240/240
(100 %)
0 diff
(100 %id)
BQ231468 melanotic melanoma, skin .a 5085 to 5953 1 to 872       872/872
(100 %)
7 diff
(99.2 %id)
DB137545 thymus .a 5170 to 5736 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA486818 brain .a 5175 to 5735 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
BG393667 embryonal carcinoma, cell line, testis .a 5206 to 5792 27 to 613       587/870
(67 %)
21 diff
(97.6 %id)
DB215409 trachea .a 5244 to 5798 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
BQ356034 head_neck .a 5282 to 5705 1 to 423       423/423
(100 %)
12 diff
(97.2 %id)
CD643086 Embryonic Stem cells .a 5457 to 6251 12 to 801       790/817
(96 %)
19 diff
(97.7 %id)
AJ430436   .a 5471 to 5752 1 to 282       282/282
(100 %)
0 diff
(100 %id)
DA071049 cerebellum .a 5508 to 6085 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
CF138520 lymph .a 5516 to 6085 1 to 570       570/570
(100 %)
5 diff
(99.2 %id)
TI_154168516   .a 5523 to 6278 92 to 850       759/801
(94 %)
26 diff
(96.8 %id)
AL137644 uterus .a 5610 to 9528 1 to 3919   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 3919/3919
(100 %)
1 diff
(100.0 %id)
TI_1607544907   .a 5659 to 6269 636 to 26       611/638
(95 %)
5 diff
(99.3 %id)
DA805913 brain .a 5679 to 6229 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BU597228 mixed (pool of 40 RNAs) .a 5698 to 6523 1 to 832       832/832
(100 %)
13 diff
(98.5 %id)
AA348189 heart .a 5766 to 6031 1 to 270       270/282
(95 %)
5 diff
(98.3 %id)
DB217659 trachea .a 5790 to 6287 2 to 500   capped   497/499
(99 %)
5 diff
(99.0 %id)
CN358458 embryonic stem cells, cell lines H1, H7, andH9 .a 5798 to 6503 1 to 706       706/706
(100 %)
6 diff
(99.2 %id)
DA391714 thalamus .a 5844 to 6427 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
CD643347 Embryonic Stem cells .a 5908 to 6597 48 to 735       688/834
(82 %)
13 diff
(98.5 %id)
AA314006 colon .a 5915 to 6432 1 to 518       518/520
(99 %)
5 diff
(99.1 %id)
AA332417 Embryo, 8 weeks .a 5916 to 6198 1 to 283       283/283
(100 %)
1 diff
(99.7 %id)
AW965318   .a 5917 to 6426 1 to 513       513/573
(89 %)
17 diff
(97.1 %id)
BF752023 breast_normal .a 5926 to 6362 14 to 450       437/450
(97 %)
1 diff
(99.8 %id)
BF752029 breast_normal .a 5933 to 6474 5 to 552       554/552
(100 %)
13 diff
(97.7 %id)
CF995568 Pooled Chondrosarcoma Tumor cells .a 5982 to 6603 1 to 629       629/930
(67 %)
22 diff
(97.7 %id)
AW367089 head_neck .a 5989 to 6634 2 to 643       642/643
(99 %)
15 diff
(97.7 %id)
TI_1607544885   .a 5998 to 6671 679 to 5       675/679
(99 %)
13 diff
(98.1 %id)
AW849166 colon .a 6000 to 6382 18 to 400       383/401
(95 %)
16 diff
(96.1 %id)
AW849180 colon .a 6009 to 6616 1 to 608       608/609
(99 %)
2 diff
(99.7 %id)
AW849703 colon .a 6009 to 6356 1 to 348       348/348
(100 %)
1 diff
(99.8 %id)
BE815299 breast_normal .a 6058 to 6360 330 to 27       304/330
(92 %)
1 diff
(99.7 %id)
AW849541 colon .a 6152 to 6765 621 to 8       614/621
(98 %)
0 diff
(100 %id)
AW367103 head_neck .a 6172 to 6755 580 to 1       580/591
(98 %)
22 diff
(96.3 %id)
DA123453 cerebellum .a 6183 to 6730 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
BG391147 embryonal carcinoma, cell line, testis .a 6185 to 6992 1 to 790       790/945
(83 %)
25 diff
(97.4 %id)
TI_1607547967   .a 6208 to 6968 1 to 762       762/762
(100 %)
5 diff
(99.4 %id)
AW849545 colon .a 6211 to 6751 541 to 1       541/541
(100 %)
0 diff
(100 %id)
AW849228 colon .a 6236 to 6751 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BF758053 colon .a 6248 to 6375 127 to 1     Submitted on the opposite strand 127/134
(94 %)
8 diff
(94.1 %id)
DA372060 thalamus .a 6252 to 6800 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
AU133686 ovary, tumor tissue .a 6285 to 6944 2 to 663   capped   662/677
(97 %)
6 diff
(99.2 %id)
BQ434551 eye, retinoblastoma .a 6301 to 6818 1 to 516       516/911
(56 %)
33 diff
(96.4 %id)
DB136632 thymus .a 6311 to 6857 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
BQ434209 embryonal carcinoma, cell line, testis .a 6314 to 7124 1 to 816       816/909
(89 %)
18 diff
(98.1 %id)
DA484701 brain .a 6329 to 6885 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
AW082975 pooled .a 6346 to 6851 511 to 3       509/535
(95 %)
11 diff
(98.0 %id)
T10694   .a 6351 to 6616 1 to 266     Submitted on the opposite strand 266/267
(99 %)
7 diff
(97.4 %id)
BI027266 marrow .a 6360 to 6744 386 to 1       386/419
(92 %)
9 diff
(97.9 %id)
AW337934 adenocarcinoma, Pancreas .a 6370 to 6851 482 to 1       482/482
(100 %)
3 diff
(99.4 %id)
AA846773   .a 6376 to 6851 478 to 3       476/478
(99 %)
2 diff
(99.6 %id)
BM147126 leukopheresis .a 6412 to 6924 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BM147396 leukopheresis .a 6412 to 6832 1 to 421       421/421
(100 %)
6 diff
(98.6 %id)
BG989167 head_neck .a 6429 to 6937 12 to 519       511/525
(97 %)
26 diff
(95.1 %id)
BI012901 lung_tumor .a 6429 to 6790 13 to 371       362/375
(96 %)
7 diff
(98.2 %id)
AW873639 pooled .a 6430 to 6851 423 to 2       422/467
(90 %)
0 diff
(100 %id)
R99646 liver and spleen .a 6441 to 6857 1 to 431       431/452
(95 %)
17 diff
(96.3 %id)
TI_1607544915   .a 6452 to 7146 710 to 16       695/719
(96 %)
7 diff
(99.1 %id)
BF766928 colon_est .a 6478 to 6653 1 to 167       167/191
(87 %)
14 diff
(92.7 %id)
DA286990 corpus callosum .a 6509 to 7077 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
TI_1607547955   .a 6535 to 7323 16 to 805       790/805
(98 %)
24 diff
(97.1 %id)
Z45094 brain, total brain .a 6553 to 6856 1 to 304       304/304
(100 %)
2 diff
(99.4 %id)
AW579773 head_neck .a 6557 to 6877 337 to 17       321/343
(93 %)
4 diff
(98.9 %id)
DN918651   .a 6605 to 6908 1 to 304       304/304
(100 %)
2 diff
(99.4 %id)
AV716298   .a 6631 to 7118 1 to 491       491/652
(75 %)
39 diff
(94.1 %id)
AW849654 colon .a 6651 to 6751 101 to 1       101/101
(100 %)
0 diff
(100 %id)
DN918652   .a 6657 to 6908 252 to 1       252/257
(98 %)
1 diff
(99.7 %id)
CD106093 brain, Pituitary .a 6685 to 7548 1 to 879       879/897
(97 %)
33 diff
(96.4 %id)
CN358452 embryonic stem cells, DMSO-treated H9 cellline .a 6700 to 7138 6 to 444       439/444
(98 %)
0 diff
(100 %id)
CB265721 adipose .a 6701 to 7308 1 to 607       607/609
(99 %)
8 diff
(98.7 %id)
AU139540 placenta .a 6702 to 7473 2 to 780   capped   779/784
(99 %)
19 diff
(97.6 %id)
CB992759 placenta, pre-eclamptic placenta .a 6730 to 7487 27 to 793       767/827
(92 %)
16 diff
(98.1 %id)
BG536777 lung .a 6855 to 7616 1 to 763       763/929
(82 %)
31 diff
(96.7 %id)
EH349198   .a 6866 to 6926 1 to 61       61/70
(87 %)
1 diff
(98.6 %id)
BU658014 blood .a 6869 to 7458 10 to 600       591/600
(98 %)
6 diff
(99.0 %id)
AW964243   .a 6882 to 7296 1 to 415       415/415
(100 %)
4 diff
(99.1 %id)
AA386023 Pancreas .a 6891 to 7108 1 to 218       218/229
(95 %)
1 diff
(99.6 %id)
BX644969   .a 6909 to 7563 1 to 655       655/655
(100 %)
0 diff
(100 %id)
N99826 liver and spleen .a 6915 to 7248 1 to 348       348/353
(98 %)
18 diff
(95.0 %id)
T80893 liver and spleen .a 6916 to 7245 1 to 336       336/365
(92 %)
11 diff
(97.0 %id)
H77791 liver and spleen .a 6916 to 7345 1 to 442       442/444
(99 %)
18 diff
(96.0 %id)
BU657836 blood .a 6944 to 7523 1 to 580       580/580
(100 %)
0 diff
(100 %id)
R95709 liver and spleen .a 6969 to 7237 1 to 271       271/271
(100 %)
2 diff
(99.3 %id)
BX482668   .a 6971 to 7621 1 to 650       650/650
(100 %)
1 diff
(99.9 %id)
TI_1607544879   .a 6982 to 7704 9 to 732       724/922
(78 %)
6 diff
(99.4 %id)
BU173110 eye, retinoblastoma .a 6992 to 7652 1 to 660       660/952
(69 %)
22 diff
(97.7 %id)
AA193217 muscle, skeletal muscle .a 6999 to 7322 1 to 331       331/331
(100 %)
10 diff
(97.0 %id)
TI_1607547961   .a 7092 to 7403 69 to 381       313/771
(40 %)
5 diff
(99.4 %id)
BF238485 bone marrow, from chronic myelogenous leukemia .a 7123 to 7791 1 to 664       664/890
(74 %)
25 diff
(97.2 %id)
TI_1607547007   .a 7146 to 8188 1128 to 97       1032/1235
(83 %)
0 diff
(100 %id)
BF694634 muscle (skeletal) .a 7155 to 7862 1 to 699       699/784
(89 %)
39 diff
(95.1 %id)
CN358450 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 7163 to 7874 36 to 747       712/747
(95 %)
6 diff
(99.2 %id)
BM701189 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 7205 to 7730 1 to 526       526/526
(100 %)
2 diff
(99.7 %id)
BM715714 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 7205 to 7907 1 to 705       705/705
(100 %)
17 diff
(97.6 %id)
TI_1607544865   .a 7207 to 7986 799 to 21       779/847
(91 %)
0 diff
(100 %id)
BX507730   .a 7263 to 7837 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
FN142006 breast carcinoma .a 7273 to 7388 1 to 116       116/116
(100 %)
3 diff
(97.5 %id)
BG898991 cartilage .a 7293 to 7883 49 to 639       591/639
(92 %)
6 diff
(99.1 %id)
T72683 liver and spleen .a 7309 to 7600 1 to 294       294/388
(75 %)
3 diff
(99.3 %id)
CD511525 Blood vessels - aorta, basilar and artery .a 7317 to 8069 1 to 766       766/779
(98 %)
19 diff
(97.6 %id)
TI_1607547957   .a 7336 to 8186 1 to 854       854/1046
(81 %)
8 diff
(99.3 %id)
FN100825 breast carcinoma .a 7372 to 7480 108 to 1     Submitted on the opposite strand 108/108
(100 %)
1 diff
(99.1 %id)
BF102592 adenocarcinoma, Prostate .a 7384 to 7995 1 to 604       604/607
(99 %)
14 diff
(97.7 %id)
BI858683 breast, mammary adenocarcinoma, cell line .a 7387 to 8114 1 to 724       724/724
(100 %)
20 diff
(97.3 %id)
TI_57191430   .a 7387 to 8114 55 to 778       724/724
(100 %)
20 diff
(97.3 %id)
N55908   .a 7393 to 7569 1 to 177       177/177
(100 %)
1 diff
(99.5 %id)
BG401364 Kidney .a 7404 to 8124 1 to 706       706/712
(99 %)
23 diff
(96.8 %id)
DN991649 brain, whole brain .a 7410 to 8078 9 to 675       667/675
(98 %)
6 diff
(99.2 %id)
TI_154037848   .a 7477 to 8302 60 to 873     Submitted on the opposite strand 814/1009
(80 %)
19 diff
(98.2 %id)
BU622270 Cell Line, Chondrosarcoma .a 7489 to 8264 789 to 16   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 774/774
(100 %)
2 diff
(99.8 %id)
CA428617 Cell Line, Chondrosarcoma .a 7496 to 8264 782 to 16   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 767/768
(99 %)
3 diff
(99.7 %id)
FN068938 breast carcinoma .a 7508 to 7613 106 to 1     Submitted on the opposite strand 106/107
(99 %)
0 diff
(100 %id)
BF106238 lung .a 7518 to 8217 1 to 690       690/888
(77 %)
25 diff
(97.2 %id)
AA418656 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 7521 to 8084 1 to 564       564/564
(100 %)
0 diff
(100 %id)
BQ277385 mixed (pool of 40 RNAs) .a 7535 to 8312 1 to 788       788/899
(87 %)
16 diff
(98.3 %id)
BF697494 brain, primitive neuroectoderm .a 7541 to 8216 1 to 664       664/853
(77 %)
14 diff
(98.4 %id)
FN057298 breast carcinoma .a 7568 to 7662 1 to 97       97/97
(100 %)
4 diff
(95.9 %id)
FN147360 breast carcinoma .a 7593 to 7701 1 to 104       104/106
(98 %)
6 diff
(94.4 %id)
CD655900 Embryonic Stem cells .a 7601 to 8418 12 to 819       808/821
(98 %)
20 diff
(97.6 %id)
AA174145   .a 7637 to 8127 1 to 490     Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 490/491
(99 %)
6 diff
(98.8 %id)
AW368341 head_neck .a 7644 to 8258 1 to 612       612/616
(99 %)
25 diff
(96.0 %id)
AW972060   .a 7647 to 8263 616 to 1     Submitted on the opposite strand 616/616
(100 %)
2 diff
(99.7 %id)
TI_1752769088   .a 7652 to 8188 719 to 182       538/721
(74 %)
0 diff
(100 %id)
AA449584   .a 7654 to 8011 1 to 359       359/359
(100 %)
2 diff
(99.5 %id)
BF224108 carcinoid, lung .a 7702 to 8267 566 to 1       566/566
(100 %)
0 diff
(100 %id)
BE550214 carcinoid, lung .a 7710 to 8263 554 to 1       554/554
(100 %)
2 diff
(99.7 %id)
BF670737 muscle (skeletal) .a 7711 to 8296 1 to 574       574/832
(68 %)
21 diff
(97.5 %id)
BQ007632 Chondrosarcoma, Left Pelvis .a 7715 to 8523 814 to 13   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 802/814
(98 %)
12 diff
(98.6 %id)
CB266289 adipose .a 7719 to 8294 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
AU158569 placenta .a 7725 to 8264 539 to 1       539/540
(99 %)
4 diff
(99.3 %id)
FN157746 breast carcinoma .a 7734 to 7841 109 to 1     Submitted on the opposite strand 109/109
(100 %)
2 diff
(98.2 %id)
AU158713 placenta .a 7742 to 8264 519 to 1       519/564
(92 %)
7 diff
(98.8 %id)
AW864397 stomach_normal .a 7747 to 8332 1 to 589       589/596
(98 %)
13 diff
(97.9 %id)
AW864463 stomach_normal .a 7752 to 8209 22 to 477       456/477
(95 %)
6 diff
(98.8 %id)
BE840976 stomach_normal .a 7752 to 8299 27 to 574       548/583
(93 %)
2 diff
(99.7 %id)
BI870416 adenocarcinoma, cell line, Liver .a 7764 to 8309 1 to 554       554/594
(93 %)
12 diff
(98.0 %id)
TI_57230893   .a 7764 to 8309 49 to 602       554/594
(93 %)
12 diff
(98.0 %id)
EC517935 Prostate .a 7767 to 7877 1 to 110       110/110
(100 %)
1 diff
(99.1 %id)
AU154918 ovary, tumor tissue .a 7770 to 8264 494 to 1       494/526
(93 %)
6 diff
(98.9 %id)
BF185360 bone marrow, from chronic myelogenous leukemia .a 7772 to 8270 1 to 500       500/891
(56 %)
11 diff
(98.8 %id)
AA910651 pooled germ cell tumors .a 7775 to 8264 490 to 1       490/490
(100 %)
1 diff
(99.8 %id)
AI131165 heart .a 7792 to 8264 473 to 1       473/473
(100 %)
1 diff
(99.8 %id)
BE646359 B-cell, chronic lymphotic leukemia .a 7795 to 8265 471 to 1       471/471
(100 %)
0 diff
(100 %id)
R95710 liver and spleen .a 7796 to 8261 480 to 7       474/485
(97 %)
0 diff
(100 %id)
AA810946 germinal center B cell .a 7799 to 8270 475 to 4       472/475
(99 %)
0 diff
(100 %id)
R19049 whole brain .a 7800 to 8234 1 to 448       448/455
(98 %)
20 diff
(95.7 %id)
AU253935 neuroblastoma .a 7813 to 8451 1 to 639       639/648
(98 %)
6 diff
(99.1 %id)
BX506922 Liver .a 7825 to 8399 1 to 580       580/580
(100 %)
16 diff
(97.3 %id)
H77622 liver and spleen .a 7825 to 8260 443 to 1       443/446
(99 %)
22 diff
(95.1 %id)
AA668778 germinal center B cell .a 7825 to 8264 450 to 11   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 440/440
(100 %)
0 diff
(100 %id)
AW294688   .a 7829 to 8264 448 to 15   AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 434/434
(100 %)
2 diff
(99.6 %id)
FN075350 breast carcinoma .a 7834 to 7937 104 to 1     Submitted on the opposite strand 104/104
(100 %)
0 diff
(100 %id)
AI636492 pooled germ cell tumors .a 7849 to 8264 416 to 1       416/416
(100 %)
0 diff
(100 %id)
BX498876 Liver .a 7850 to 8493 1 to 644       644/644
(100 %)
3 diff
(99.6 %id)
BU570144 testis .a 7854 to 8579 1 to 740       740/789
(93 %)
23 diff
(97.1 %id)
R99104 liver and spleen .a 7861 to 8243 389 to 1       389/397
(97 %)
5 diff
(98.8 %id)
FN160980 breast carcinoma .a 7868 to 7981 118 to 4     Submitted on the opposite strand 115/118
(97 %)
0 diff
(100 %id)
T91175 liver and spleen .a 7868 to 8265 415 to 3       413/488
(84 %)
0 diff
(100 %id)
AW805508 uterus .a 7871 to 8217 1 to 348       348/348
(100 %)
7 diff
(98.0 %id)
AI802090 carcinoid, lung .a 7877 to 8263 387 to 1       387/387
(100 %)
4 diff
(99.0 %id)
AW150158 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 7877 to 8345 469 to 1       469/469
(100 %)
0 diff
(100 %id)
FN146449 breast carcinoma .a 7909 to 8004 93 to 1     Submitted on the opposite strand 93/94
(98 %)
3 diff
(96.9 %id)
N70687 liver and spleen .a 7918 to 8264 349 to 1       349/350
(99 %)
1 diff
(99.8 %id)
FN063757 breast carcinoma .a 7925 to 8047 1 to 123       123/123
(100 %)
1 diff
(99.2 %id)
AW805502 uterus .a 7926 to 8210 1 to 288       288/288
(100 %)
17 diff
(94.1 %id)
T70316 liver and spleen .a 7926 to 8261 347 to 5       343/348
(98 %)
0 diff
(100 %id)
T72613 liver and spleen .a 7931 to 8262 338 to 7       332/342
(97 %)
0 diff
(100 %id)
BE874937 large cell carcinoma, undifferentiated, lung .a 7932 to 8259 1 to 326       326/326
(100 %)
2 diff
(99.4 %id)
BG392342 embryonal carcinoma, cell line, testis .a 7944 to 8731 1 to 772       772/796
(96 %)
20 diff
(97.5 %id)
Z40829 brain, total brain .a 7952 to 8264 313 to 1       313/313
(100 %)
1 diff
(99.7 %id)
AA042866 uterus .a 7983 to 8325 1 to 341       341/342
(99 %)
8 diff
(97.7 %id)
BF977512 melanotic melanoma, high MDR, skin .a 7983 to 8555 1 to 576       576/576
(100 %)
18 diff
(96.9 %id)
BG612528 embryonal carcinoma, testis .a 7988 to 8620 1 to 627       627/628
(99 %)
18 diff
(97.2 %id)
TI_149291596   .a 8001 to 8795 847 to 55       793/1003
(79 %)
0 diff
(100 %id)
FN143882 breast carcinoma .a 8053 to 8157 1 to 106       106/113
(93 %)
4 diff
(96.5 %id)
BF381696 brain, primitive neuroectoderm .a 8061 to 8716 1 to 663       663/915
(72 %)
23 diff
(97.5 %id)
BG426689 Kidney .a 8076 to 8868 1 to 786       786/806
(97 %)
46 diff
(94.3 %id)
BM556432 amelanotic melanoma, cell line, skin .a 8082 to 8786 28 to 731       704/758
(92 %)
4 diff
(99.5 %id)
BM974204 lung .a 8097 to 8773 693 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 675/675
(100 %)
2 diff
(99.8 %id)
BF701374 brain, primitive neuroectoderm .a 8135 to 8796 1 to 654       654/853
(76 %)
24 diff
(97.2 %id)
BF212967 bone marrow, from chronic myelogenous leukemia .a 8136 to 8816 1 to 671       671/672
(99 %)
35 diff
(94.8 %id)
BG483415 lung .a 8136 to 8794 1 to 666       666/786
(84 %)
34 diff
(95.7 %id)
BG687481 lung, mucoepidermoid carcinoma .a 8137 to 8934 1 to 793       793/856
(92 %)
34 diff
(96.1 %id)
FN099250 breast carcinoma .a 8146 to 8248 1 to 98       98/98
(100 %)
4 diff
(96.0 %id)
BF240355 bone marrow, from chronic myelogenous leukemia .a 8151 to 8772 1 to 621       621/824
(75 %)
61 diff
(92.6 %id)
AW242513 Kidney .a 8169 to 8780 613 to 4       610/613
(99 %)
0 diff
(100 %id)
AI741829 pooled .a 8186 to 8772 587 to 1       587/587
(100 %)
1 diff
(99.9 %id)
BG615285 embryonal carcinoma, testis .a 8204 to 9013 1 to 814       814/815
(99 %)
28 diff
(96.6 %id)
DB379915 placenta .a 8204 to 8773 568 to 1       568/570
(99 %)
15 diff
(97.4 %id)
BF697464 brain, primitive neuroectoderm .a 8206 to 8777 1 to 561       561/817
(68 %)
30 diff
(96.4 %id)
CN479333 Bone, Subchondral Bone .a 8239 to 8773 553 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 535/544
(98 %)
0 diff
(100 %id)
AA557208 breast .a 8241 to 8772 533 to 1       533/533
(100 %)
2 diff
(99.7 %id)
BM993802 Bone, Subchondral Bone .a 8250 to 8773 542 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 524/524
(100 %)
0 diff
(100 %id)
AA418594 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 8258 to 8773 519 to 1       519/519
(100 %)
2 diff
(99.7 %id)
BF446529 carcinoid, lung .a 8272 to 8774 505 to 3       503/505
(99 %)
0 diff
(100 %id)
BF210614 bone marrow, from chronic myelogenous leukemia .a 8284 to 8922 1 to 636       636/637
(99 %)
17 diff
(97.4 %id)
BF110554 carcinoid, lung .a 8305 to 8774 472 to 3       470/472
(99 %)
0 diff
(100 %id)
BM698316 eye, fetal eyes .a 8307 to 8620 1 to 314     Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 314/314
(100 %)
1 diff
(99.7 %id)
BM989264 Fibrosarcoma .a 8314 to 8773 477 to 18   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 460/460
(100 %)
0 diff
(100 %id)
BE710344 head_neck .a 8322 to 8460 1 to 140       140/140
(100 %)
10 diff
(92.9 %id)
AI022383 liver and spleen .a 8328 to 8773 447 to 1       447/447
(100 %)
3 diff
(99.4 %id)
T10721   .a 8336 to 8522 187 to 1       187/189
(98 %)
1 diff
(99.5 %id)
AW090786 brain, tumor, 5 pooled (see description) .a 8338 to 8792 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AA551771 colon .a 8344 to 8773 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AA825153 carcinoid, lung .a 8346 to 8772 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AI307392 2 pooled tumors (clear cell type), Kidney .a 8352 to 8778 427 to 1       427/427
(100 %)
1 diff
(99.8 %id)
EC580460 Prostate .a 8357 to 8464 1 to 108       108/110
(98 %)
1 diff
(99.1 %id)
FN143910 breast carcinoma .a 8357 to 8429 73 to 1     Submitted on the opposite strand 73/74
(98 %)
0 diff
(100 %id)
BF664641 brain, primitive neuroectoderm .a 8358 to 9015 1 to 640       640/832
(76 %)
33 diff
(96.1 %id)
AI278436 placenta .a 8363 to 8780 420 to 2       419/420
(99 %)
0 diff
(100 %id)
H99707 melanocyte .a 8373 to 8773 403 to 1       403/404
(99 %)
2 diff
(99.6 %id)
AA733000 heart .a 8377 to 8777 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AI122918 pooled .a 8378 to 8777 400 to 1       400/400
(100 %)
1 diff
(99.8 %id)
AI678973 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 8380 to 8773 427 to 34   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 394/394
(100 %)
14 diff
(96.5 %id)
AA449326   .a 8382 to 8774 395 to 3       393/395
(99 %)
0 diff
(100 %id)
W87001 liver and spleen .a 8385 to 8773 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
AA193218 muscle, skeletal muscle .a 8411 to 8770 360 to 1       360/360
(100 %)
0 diff
(100 %id)
AW262242 lung, two pooled squamous cell carcinomas .a 8414 to 8786 372 to 1       372/372
(100 %)
4 diff
(99.0 %id)
AA044417 uterus .a 8430 to 8773 352 to 1       352/388
(90 %)
11 diff
(97.2 %id)
AI266651 placenta .a 8445 to 8774 332 to 3       330/332
(99 %)
0 diff
(100 %id)
AW614519 carcinoid, lung .a 8447 to 8774 331 to 3       329/331
(99 %)
0 diff
(100 %id)
FN089626 breast carcinoma .a 8456 to 8570 111 to 1     Submitted on the opposite strand 111/111
(100 %)
4 diff
(96.4 %id)
FN124017 breast carcinoma .a 8475 to 8586 1 to 110       110/110
(100 %)
4 diff
(96.4 %id)
FN046154 breast carcinoma .a 8476 to 8532 56 to 1     Submitted on the opposite strand 56/57
(98 %)
1 diff
(98.3 %id)
AI351781 pooled germ cell tumors .a 8481 to 8947 469 to 1       469/469
(100 %)
10 diff
(97.9 %id)
BF825335 head_normal .a 8491 to 8691 203 to 2     Submitted on the opposite strand 202/208
(97 %)
0 diff
(100 %id)
AA176690   .a 8492 to 8773 299 to 18   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 282/288
(97 %)
2 diff
(99.4 %id)
BQ427500 melanotic melanoma, skin .a 8497 to 9342 28 to 875       848/894
(94 %)
17 diff
(98.1 %id)
FN143865 breast carcinoma .a 8523 to 8631 108 to 1     Submitted on the opposite strand 108/109
(99 %)
3 diff
(97.3 %id)
FN051342 breast carcinoma .a 8546 to 8613 1 to 68       68/69
(98 %)
2 diff
(97.2 %id)
CR748699   .a 8564 to 9202 1 to 641       641/641
(100 %)
4 diff
(99.4 %id)
AA425079 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 8564 to 8742 1 to 180       180/180
(100 %)
3 diff
(98.4 %id)
AW964063   .a 8579 to 9151 581 to 1     Submitted on the opposite strand 581/583
(99 %)
17 diff
(97.1 %id)
AI435168 pooled .a 8614 to 9072 463 to 5       459/463
(99 %)
0 diff
(100 %id)
FN079229 breast carcinoma .a 8638 to 8705 67 to 1     Submitted on the opposite strand 67/68
(98 %)
1 diff
(98.6 %id)
DB484431 hypothalamus .a 8675 to 9107 1 to 434       434/434
(100 %)
4 diff
(99.1 %id)
M85549   .a 8697 to 9028 332 to 1       332/335
(99 %)
2 diff
(99.5 %id)
DT215583 brain .a 8700 to 9128 1 to 427       427/427
(100 %)
5 diff
(98.9 %id)
AV733758 pheochromocytoma .a 8835 to 9409 1 to 570       570/609
(93 %)
24 diff
(96.1 %id)
AI536622 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 8896 to 9221 21 to 346     Submitted on the opposite strand 326/346
(94 %)
14 diff
(96.0 %id)
BM667028 eye, fetal eyes .a 8899 to 9528 648 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 630/630
(100 %)
1 diff
(99.9 %id)
BI964015 Islets of Langerhans, Pancreas .a 8913 to 9496 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
AA353413   .a 8914 to 9152 239 to 1     Submitted on the opposite strand 239/239
(100 %)
1 diff
(99.6 %id)
BU737344 eye, fetal eyes .a 8947 to 9528 600 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 582/582
(100 %)
0 diff
(100 %id)
BE466618 pooled germ cell tumors .a 9004 to 9525 524 to 3       522/524
(99 %)
0 diff
(100 %id)
BE466662 pooled germ cell tumors .a 9023 to 9530 511 to 4       508/511
(99 %)
0 diff
(100 %id)
AA496000 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 9027 to 9536 514 to 5       510/514
(99 %)
0 diff
(100 %id)
DB552593 hippocampus .a 9053 to 9530 1 to 477     Submitted on the opposite strand 477/479
(99 %)
2 diff
(99.6 %id)
AI702078 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 9059 to 9528 470 to 1       470/470
(100 %)
0 diff
(100 %id)
AI250775 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 9060 to 9528 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AI659133 Prostate .a 9062 to 9528 467 to 1       467/467
(100 %)
2 diff
(99.6 %id)
AW029439 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 9062 to 9528 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
AI800652 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 9070 to 9528 460 to 1       460/460
(100 %)
2 diff
(99.6 %id)
BM987918 mixed .a 9071 to 9528 476 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 458/458
(100 %)
1 diff
(99.8 %id)
BE045664 carcinoid, lung .a 9072 to 9530 464 to 6       459/464
(98 %)
0 diff
(100 %id)
AI342915 carcinoid, lung .a 9094 to 9530 441 to 6       436/441
(98 %)
0 diff
(100 %id)
DB553381 hypothalamus .a 9105 to 9526 1 to 420     Submitted on the opposite strand 420/421
(99 %)
12 diff
(97.2 %id)
FN067725 breast carcinoma .a 9106 to 9196 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
AI342681 carcinoid, lung .a 9119 to 9530 417 to 6       412/417
(98 %)
0 diff
(100 %id)
AI537979 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 9119 to 9530 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
R44036 whole brain .a 9147 to 9530 395 to 7       389/398
(97 %)
0 diff
(100 %id)
AI783734 Prostate .a 9160 to 9519 376 to 15       362/376
(96 %)
0 diff
(100 %id)
BI465267 testis .a 9182 to 9528 1 to 347   available from MGC, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 347/347
(100 %)
11 diff
(96.9 %id)
BF436507 breast, invasive ductal carcinoma, 3 pooled samples .a 9183 to 9530 357 to 10       348/358
(97 %)
0 diff
(100 %id)
BC038768 testis .a 9187 to 9528 1 to 342   available from MGC, AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 342/342
(100 %)
0 diff
(100 %id)
AA857374 ovary .a 9216 to 9528 1 to 313   AAA Submitted on the opposite strand 313/313
(100 %)
2 diff
(99.4 %id)
AI267518 brain, frontal lobe (see description) .a 9242 to 9506 23 to 285       263/285
(92 %)
6 diff
(97.9 %id)
CA444860 lung, Metastatic Chondrosarcoma .a 9273 to 9528 274 to 19   AAA Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) 256/256
(100 %)
2 diff
(99.3 %id)
AI682112 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 9408 to 9528 121 to 1       121/121
(100 %)
1 diff
(99.2 %id)
BM144523 leukopheresis .a 9409 to 9530 136 to 15       122/140
(87 %)
0 diff
(100 %id)
FN126325 breast carcinoma .a 9414 to 9527 116 to 3     Submitted on the opposite strand 114/116
(98 %)
0 diff
(100 %id)
AI468815 lymph node, lymphoma, follicular mixed small and largecell .a 9430 to 9528 99 to 1       99/99
(100 %)
0 diff
(100 %id)
CN358457 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1 to 702 1 to 702   tiling clone,   702/702
(100 %)
4 diff
(99.5 %id)
BE810950 amnion_normal .b 347 to 710 364 to 2       363/364
(99 %)
0 diff
(100 %id)
BE810951 amnion_normal .b 347 to 706 360 to 1       360/360
(100 %)
5 diff
(98.7 %id)
DA780949 brain .b 407 to 990 2 to 585   tiling clone, capped   584/584
(100 %)
0 diff
(100 %id)
BI022601 marrow .c-u 593 to 849 1 to 257   tiling clone,   257/257
(100 %)
8 diff
(96.9 %id)
CV363301 breast .c-u 1735 to 2006 15 to 285       271/291
(93 %)
5 diff
(98.3 %id)
CV363318 breast .c-u 1735 to 2006 38 to 308       271/314
(86 %)
5 diff
(98.5 %id)
CV363327 breast .c-u 1735 to 2006 277 to 6   tiling clone, Submitted on the opposite strand 272/289
(94 %)
0 diff
(100 %id)
DA483354 brain .c-u 2024 to 2736 2 to 714   tiling clone, to resequence, capped   713/713
(100 %)
5 diff
(99.3 %id)
FN160964 breast carcinoma .c-u 3263 to 3366 1 to 102   tiling clone,   102/103
(99 %)
5 diff
(95.2 %id)
AA992669   .c-u 3305 to 3735 431 to 1   tiling clone,   431/431
(100 %)
0 diff
(100 %id)
AA502152 liposarcoma .c-u 3347 to 3544 312 to 115       198/312
(63 %)
0 diff
(100 %id)
FN168801 breast carcinoma .c-u 3369 to 3480 1 to 111       111/114
(97 %)
2 diff
(98.3 %id)
DB315010 brain .c-u 3419 to 3961 545 to 1   to resequence,   545/545
(100 %)
3 diff
(99.5 %id)
FN055310 breast carcinoma .c-u 3450 to 3561 1 to 112       112/112
(100 %)
0 diff
(100 %id)
N51932 multiple sclerosis lesions .c-u 3476 to 3961 488 to 1   tiling clone,   488/488
(100 %)
6 diff
(98.8 %id)
FN078217 breast carcinoma .c-u 3481 to 3583 102 to 1     Submitted on the opposite strand 102/110
(92 %)
0 diff
(100 %id)
FN097591 breast carcinoma .c-u 3635 to 3745 1 to 116       116/119
(97 %)
7 diff
(94.2 %id)
FN164891 breast carcinoma .c-u 3852 to 3960 1 to 109       109/111
(98 %)
1 diff
(99.1 %id)
BG527662 lung, mucoepidermoid carcinoma .d 1 to 676 1 to 676 W153G tiling clone,   676/676
(100 %)
13 diff
(98.1 %id)
H82483 melanocyte .d 256 to 705 1 to 461       461/461
(100 %)
10 diff
(97.9 %id)
N42662 melanocyte .d 256 to 558 1 to 302       302/302
(100 %)
1 diff
(99.7 %id)
BX112603 melanocyte .d 257 to 1041 1 to 786   tiling clone,   786/786
(100 %)
1 diff
(99.9 %id)
BP426195 small intestine .d 272 to 590 1 to 319     Submitted on the opposite strand 319/319
(100 %)
0 diff
(100 %id)
AW294270   .d 291 to 623 350 to 18   AAA   333/333
(100 %)
0 diff
(100 %id)
DA423320   .d 1054 to 1586 2 to 534   tiling clone, capped   533/533
(100 %)
0 diff
(100 %id)
CN310916 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1108 to 1710 1 to 603   tiling clone,   603/611
(98 %)
1 diff
(99.9 %id)
FN177564 breast carcinoma .d 1120 to 1227 1 to 105       105/105
(100 %)
4 diff
(96.2 %id)
N31603 melanocyte .d 1129 to 1551 423 to 1       423/423
(100 %)
4 diff
(99.1 %id)
AA888410 metastatic prostate bone lesion .d 1316 to 1552 1 to 237       237/252
(94 %)
3 diff
(98.9 %id)
N73290 melanocyte .d 1432 to 1642 212 to 1       212/212
(100 %)
1 diff
(99.6 %id)
AK025348 colon .d 1619 to 4579 1 to 2961   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (25/26 A in genome downstream of last aligned base) 2961/2961
(100 %)
5 diff
(99.9 %id)
BF329580 breast_normal .d 3570 to 3767 1 to 199       199/199
(100 %)
11 diff
(94.5 %id)
BX113541 liver and spleen .d 3720 to 4503 1 to 787   tiling clone,   787/787
(100 %)
4 diff
(99.5 %id)
N80346 liver and spleen .d 3756 to 4146 1 to 395       395/395
(100 %)
7 diff
(98.3 %id)
N62571 liver and spleen .d 4155 to 4579 426 to 1       426/426
(100 %)
5 diff
(98.9 %id)
BX103984   .e 1 to 489 1 to 489   tiling clone,   489/489
(100 %)
0 diff
(100 %id)
AV762717 bone marrow .e 401 to 861 1 to 457   tiling clone,   457/465
(98 %)
8 diff
(98.3 %id)
AV762718 bone marrow .e 409 to 853 1 to 444   tiling clone,   444/466
(95 %)
35 diff
(92.5 %id)
AI150180   .e 528 to 985 460 to 3   tiling clone,   458/460
(99 %)
0 diff
(100 %id)
AA758988   .e 544 to 985 443 to 3       441/443
(99 %)
0 diff
(100 %id)
FN087517 breast carcinoma .e 790 to 881 92 to 1     Submitted on the opposite strand 92/92
(100 %)
1 diff
(99.0 %id)
DB473366 hippocampus .f 1 to 492 1 to 492 exact tiling clone,   492/492
(100 %)
1 diff
(99.8 %id)
DB483650 hippocampus .f 1 to 455 1 to 455       455/455
(100 %)
1 diff
(99.8 %id)
CR975513 T-Lymphocytes .g 1 to 665 1 to 664 exact tiling clone,   664/664
(100 %)
2 diff
(99.7 %id)
BX641535   .h-u 1 to 519 1 to 519 C53X tiling clone,   519/519
(100 %)
1 diff
(99.9 %id)
AL603573 human skeletal muscle .h-u 381 to 964 1 to 585   tiling clone,   585/585
(100 %)
3 diff
(99.5 %id)
AA634363   .i 1 to 414 414 to 1 exact tiling clone,   414/414
(100 %)
0 diff
(100 %id)
BG204048   .i 188 to 398 225 to 15     Submitted on the opposite strand 211/225
(93 %)
0 diff
(100 %id)
DB067576 testis .j 1 to 503 2 to 505   tiling clone, capped   504/504
(100 %)
1 diff
(99.9 %id)
DN920398   .j 49 to 567 1 to 519 K6R R64X H90Y tiling clone,   519/520
(99 %)
5 diff
(99.1 %id)
DB146673 thymus .k 1 to 530 2 to 531 exact tiling clone, capped   530/530
(100 %)
1 diff
(99.9 %id)
BM798461 Ascites, stomach .l 1 to 188 1 to 188 H11R K12R tiling clone,   188/188
(100 %)
2 diff
(99.0 %id)
DA854542 placenta .m 1 to 484 2 to 485 V28X tiling clone, capped   484/484
(100 %)
2 diff
(99.6 %id)
BY795912 eye .n-u 1 to 627 1 to 627 exact tiling clone,   627/627
(100 %)
0 diff
(100 %id)
AV704416 adrenal gland Gene MED13L, variant not shown         Suspected internal deletion, this clone was ignored    
AK025280 colon Gene MED13L, variant not shown       AAA      
BF333150 breast Gene MED13L, variant not shown         Suspected internal deletion, this clone was ignored    
DA229143 brain Gene MED13L, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB305517 brain Gene MED13L, variant not shown         This clone was ignored    
DA232027 brain Gene MED13L, variant not shown       capped This clone was ignored    
AA007546 liver and spleen Gene MED13L, variant not shown         This clone was ignored    
AA007547 liver and spleen Gene MED13L, variant not shown         This clone was ignored    
DB067937 testis Gene MED13L, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB198038 trachea Gene MED13L, variant not shown       capped Suspected internal deletion, this clone was ignored    
BM699496 eye, fetal eyes Gene MED13L, variant not shown         Suspected internal deletion, this clone was ignored    
BU737235 eye, fetal eyes Gene MED13L, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f, .g, .h-u, .i, .j, .k, .l, .m, .n-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI